Stem Cell Committee

The Stem Cell committee is responsible for the creation of an Annual Meeting symposium and other programs with a focus on stem cell biology and stem cell applications that are relevant for cell and gene therapies. The committee’s scope includes the following areas: using allogeneic or autologous pluripotent stem cells as a target for ex vivo gene and cell therapies, using allogeneic or autologous adult stem cells as targets for ex vivo and in vivo gene and cell therapies (for example, hematopoietic stem cells), and applying basic knowledge from stem cell and regenerative biology to target non-stem cells but to achieve durable treatment effects.
Full NamePositionOrganizationTerm StartTerm End
Dan S. Kaufman, MD, PhDChairUniversity of California - San Diego6/1/20265/31/20278407
Agnieszka Czechowicz, MD, PhDMemberStanford University, School of Medicine6/1/20255/31/202822041
David L. Mack, PhDMemberUniversity of Washington6/1/20235/31/202921715
Amy Wagers, PhDMemberHarvard University6/1/20245/31/202725132
April D. Pyle, PhDMemberUCLA6/1/20235/31/202723302
Daniel E. Bauer, MD, PhDMemberBoston Children's Hospital/Harvard Medical School6/1/20255/31/202825610
Scott G. Kitchen, PhDMemberDavid Geffen School of Medicine at UCLA6/1/20245/31/202724734
Sjoukje van Der Stegen, PhDMemberBiohub NY6/1/20265/31/202923746
Yakaka Alhaji BulamaMemberUniversity of Maiduguri Teaching Hospital6/1/20255/31/202887442
Jing Fan, PhDMemberHopstem Biotechnology6/1/20245/31/202759103
Giulia Pavani, PhDMemberChildren's Hospital of Philadelphia6/1/20245/31/202723993
Zulema Romero Garcia, PhDMemberUCLA6/1/20255/31/202818923
Peter Andersen, PhDMemberJHU/Treefrog Tx6/1/20265/31/202959210
Gretchen LewisMemberPfizer - Cambridge, MA6/1/20245/31/202725861
Danielle GaleStaff LiaisonASGCT6/1/20215/31/204535359